Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/rgwp-s352

poster

AMA Research Challenge 2024

November 07, 2024

Virtual only, United States

Methylene Blue Use for Refractory Hypotension in Setting of Necrotizing Pancreatitis 

Methylene blue is controversially used in the management of refractory vasoplegia and septic shock due to its mechanism of inhibiting guanylate cyclase and decreasing cGMP levels to improve vascular tone. In recent meta-analysis, methylene blue use in septic shock resulted in improvement of hypotension, blood pressure, and cardiac function, while significantly reducing mortality and ICU/hospital stays. Further usage of methylene blue may benefit anaphylactic and drug-induced shock by reducing vasopressor requirements. Administered intravenously, methylene blue peaks at 30 minutes, with effects lasting 48–72 hours, making it a valuable treatment for various shock conditions.

Next from AMA Research Challenge 2024

Postoperative Opioid Use for Regional vs. General Anesthesia in Hip Arthroplasty
poster

Postoperative Opioid Use for Regional vs. General Anesthesia in Hip Arthroplasty

AMA Research Challenge 2024

Harmandeep Singh

07 November 2024

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved